WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009067204) METHOD OF SCREENING FOR CANCER BY DETECTING MUTATIONS IN THE DELTA-CATENIN GENE PROMOTER AND 5'-UNTRANSLATED REGION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/067204    International Application No.:    PCT/US2008/012906
Publication Date: 28.05.2009 International Filing Date: 19.11.2008
IPC:
C12Q 1/68 (2006.01), C12N 15/01 (2006.01)
Applicants: EAST CAROLINA UNIVERSITY [US/US]; 2200 Charles Boulevard, Greenville Centre, Room 2400, Greenville, North Carolina 27858 (US) (For All Designated States Except US).
LU, Qun [US/US]; (US) (For US Only)
Inventors: LU, Qun; (US)
Agent: MYERS BIGEL SIBLEY & SAJOVEC, P.A.; P.O. Box 37428, Raleigh, North Carolina 27627 (US)
Priority Data:
60/989,158 20.11.2007 US
Title (EN) METHOD OF SCREENING FOR CANCER BY DETECTING MUTATIONS IN THE DELTA-CATENIN GENE PROMOTER AND 5'-UNTRANSLATED REGION
(FR) PROCÉDÉ DE CRIBLAGE POUR LE CANCER PAR DÉTECTION DE MUTATIONS DANS LE PROMOTEUR DU GÈNE DE LA DELTA-CATÉNINE ET LA RÉGION NON TRADUITE EN 5'
Abstract: front page image
(EN)A method for screening for risk of cancer in a subject is carried out by detecting the presence or absence of at least one mutation in the delta-catenin gene promoter or 5' untranslated region in a biological sample from said subject, the presence of such mutation or an increased frequency of mutation indicating said subject is afflicted with or at least at risk of developing cancer.
(FR)L'invention porte sur un procédé de criblage pour un risque de cancer chez un sujet qui est effectué par la détection de la présence ou de l'absence d'au moins une mutation dans le promoteur du gène de la delta-caténine ou la région non traduite en 5' dans un échantillon biologique provenant dudit sujet, la présence d'une telle mutation ou une fréquence accrue de mutation indiquant que ledit sujet est atteint d'un cancer ou au moins encourt le risque de développer un cancer.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)